Minority Powerbrokers Q&A: Paul Hastings' Preston Ratliff
Law360, New York (February 9, 2015, 10:17 AM EST) -- Preston K. Ratliff II is the chairman of Paul Hastings LLP's litigation practice in New York. He focuses his practice on complex, high-stakes litigation with an emphasis on patent actions in the pharmaceutical, biotechnology and chemical arts. He has successfully represented major and emerging corporations both pretrial and at trial.
Ratliff has experience with a broad range of technologies in the pharmaceutical field, including proton pump inhibitors, anti-epileptic agents, anti-hypertensive agents and respiratory agents. Ratliff also has experience counseling clients with respect to their intellectual property portfolios and evaluating strategic licensing opportunities.
As a participant in Law360's Minority Powerbrokers Q&A series,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!